A multicenter prospective cohort study evaluating impact of an active delisting strategy to enable kidney transplantation in wait-listed candidates with calculated Panel Reactive Antibody ≥ 99.9%
Authors:
- 6 June 2025
- journal article
- Published by Elsevier in Kidney International
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting ReportAmerican Journal of Transplantation, 2023
- Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)Transplantation, 2020
- Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant OutcomeKidney International Reports, 2018
- Impact of persistent and cleared preformed HLA DSA on kidney transplant outcomesHuman Immunology, 2018
- Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patientsKidney International, 2018
- Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSATransplantation, 2017
- High HLA-DP Expression and Graft-versus-Host DiseaseNew England Journal of Medicine, 2015
- Clinical relevance of pretransplant anti-HLA donor-specific antibodies: Does C1q-fixation matter?Transplant Immunology, 2013
- Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantationNephrology Dialysis Transplantation, 2011
- Evaluation of Intravenous Immunoglobulin as an Agent to Lower Allosensitization and Improve Transplantation in Highly Sensitized Adult Patients with End-Stage Renal DiseaseJournal of the American Society of Nephrology, 2004